Langenberg, Karin P S; Meister, Michael T; Bakhuizen, Jette J; Boer, Judith M; van Eijkelenburg, Natasha K A; Hulleman, Esther; Ilan, Uri; Looze, Eleonora J; Dierselhuis, Miranda P; van der Lugt, Jasper; Breunis, Willemijn; Schild, Linda G; Ober, Kimberley; van Hooff, Sander R; Scheijde-Vermeulen, Marijn A; Hiemcke-Jiwa, Laura S; Flucke, Uta E; Kranendonk, Mariette E G; Wesseling, Pieter; Sonneveld, Edwin; Punt, Simone; Boltjes, Arjan; van Dijk, Freerk; Verwiel, Eugene T P; Volckmann, Richard; Hehir-Kwa, Jayne Y; Kester, Lennart A; Koudijs, Marco M J; Waanders, Esme; Holstege, Frank C P; Vormoor, H Josef; Hoving, Eelco W; van Noesel, Max M; Pieters, Rob; Kool, Marcel; Stumpf, Miriam; Blattner-Johnson, Mirjam; Balasubramanian, Gnana P; Van Tilburg, Cornelis M; Jones, Barbara C; Jones, David T W; Witt, Olaf; Pfister, Stefan M; Jongmans, Marjolijn C J; Kuiper, Roland P; de Krijger, Ronald R; Wijnen, Marc H W; den Boer, Monique L; Zwaan, C Michel; Kemmeren, Patrick; Koster, Jan; Tops, Bastiaan B J; Goemans, Bianca F; Molenaar, Jan J
(Elsevier Limited, 2022-11)
iTHER is a Dutch prospective national precision oncology program aiming to define tumour molecular profiles in children and adolescents with primary very high-risk, relapsed, or refractory paediatric tumours. Between April ...